Ginés Luengo‐Gil

899 total citations
35 papers, 644 citations indexed

About

Ginés Luengo‐Gil is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ginés Luengo‐Gil has authored 35 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Ginés Luengo‐Gil's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Extracellular vesicles in disease (5 papers). Ginés Luengo‐Gil is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Extracellular vesicles in disease (5 papers). Ginés Luengo‐Gil collaborates with scholars based in Spain, Italy and United States. Ginés Luengo‐Gil's co-authors include Vicente Vicente, Francisco Ayala, Enrique González‐Billalabeitia, Elisa García-Garré, Teresa García, M.A. Vicente Conesa, Elena García-Martínez, Esther Navarro Manzano, Elena García-Martínez and Pablo Conesa‐Zamora and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ginés Luengo‐Gil

33 papers receiving 640 citations

Peers

Ginés Luengo‐Gil
Dan G. Duda United States
Dongyin Yu United States
Nina Sausgruber Switzerland
Jeannine Diesch Australia
Sangok Kim South Korea
James R. Hernandez United States
Allen Saliganan United States
Ginés Luengo‐Gil
Citations per year, relative to Ginés Luengo‐Gil Ginés Luengo‐Gil (= 1×) peers Maria Pavlaki

Countries citing papers authored by Ginés Luengo‐Gil

Since Specialization
Citations

This map shows the geographic impact of Ginés Luengo‐Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginés Luengo‐Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginés Luengo‐Gil more than expected).

Fields of papers citing papers by Ginés Luengo‐Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginés Luengo‐Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginés Luengo‐Gil. The network helps show where Ginés Luengo‐Gil may publish in the future.

Co-authorship network of co-authors of Ginés Luengo‐Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Ginés Luengo‐Gil. A scholar is included among the top collaborators of Ginés Luengo‐Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginés Luengo‐Gil. Ginés Luengo‐Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luengo‐Gil, Ginés, et al.. (2025). Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report. Journal of Clinical Medicine. 14(4). 1333–1333. 1 indexed citations
2.
García‐Rodríguez, José, et al.. (2025). Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers. International Journal of Molecular Sciences. 26(7). 3076–3076. 2 indexed citations
3.
Ramos, María C., et al.. (2025). Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer. Scientific Reports. 15(1). 14906–14906. 1 indexed citations
4.
García‐Rodríguez, José, Rikke Borg, Edith Rodríguez-Braun, et al.. (2025). Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Scientific Reports. 15(1). 21626–21626.
5.
Jiménez‐Fonseca, Paula, Carmen González del Rey, Milagros Balbı́n, et al.. (2025). Dysfunctional mismatch repair in patients with early triple-negative breast cancer. Clinical & Translational Oncology. 27(10). 3924–3937. 1 indexed citations
6.
Montoro‐García, Silvia, Ángel Bernabé‐García, Irene Luque, et al.. (2024). Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway. Biomedicine & Pharmacotherapy. 175. 116785–116785. 1 indexed citations
8.
Peña‐García, Jorge, Ginés Luengo‐Gil, Francisco Garcı́a-Molina, et al.. (2023). Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells. Frontiers in Molecular Biosciences. 10. 1182925–1182925. 2 indexed citations
9.
Manzano, Esther Navarro, Ginés Luengo‐Gil, Rocío Gónzález‐Conejero, et al.. (2022). Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer. Cancers. 14(10). 2390–2390. 12 indexed citations
10.
Garrido, Pedro, Paula Jiménez‐Fonseca, Eva Martínez de Castro, et al.. (2022). Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry. Biomedicines. 10(1). 148–148. 6 indexed citations
11.
Luengo‐Gil, Ginés, et al.. (2022). Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data. Methods in molecular biology. 2547. 165–185. 7 indexed citations
12.
Luengo‐Gil, Ginés, Elena García-Martínez, Pablo Conesa‐Zamora, et al.. (2019). Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy. Cellular Oncology. 42(5). 627–644. 32 indexed citations
13.
Teruel‐Montoya, Raúl, Ginés Luengo‐Gil, Fernando Vallejo, et al.. (2019). Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria. Scientific Reports. 9(1). 3611–3611. 13 indexed citations
14.
Luengo‐Gil, Ginés, Enrique González‐Billalabeitia, Esther Navarro Manzano, et al.. (2018). Angiogenic role of miR-20a in breast cancer. PLoS ONE. 13(4). e0194638–e0194638. 58 indexed citations
15.
Luengo‐Gil, Ginés, Enrique González‐Billalabeitia, Vanessa Roldán, et al.. (2018). Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. Breast Cancer Research and Treatment. 169(1). 83–92. 13 indexed citations
16.
Arroyo, Ana B., Salam Salloum‐Asfar, C. Pérez‐Sánchez, et al.. (2017). Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens. Scientific Reports. 7(1). 43500–43500. 19 indexed citations
17.
Luengo‐Gil, Ginés, María I. Calvo-Sánchez, Ester Martín-Villar, et al.. (2016). Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase. Scientific Reports. 6(1). 27544–27544. 34 indexed citations
18.
Luengo‐Gil, Ginés, et al.. (2015). Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis. Breast Cancer Research and Treatment. 151(3). 577–587. 18 indexed citations
19.
Salloum‐Asfar, Salam, Raúl Teruel‐Montoya, Ana B. Arroyo, et al.. (2014). Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver. PLoS ONE. 9(11). e111713–e111713. 29 indexed citations
20.
García-Martínez, Elena, Ginés Luengo‐Gil, Enrique González‐Billalabeitia, et al.. (2014). Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer. Breast Cancer Research. 16(6). 488–488. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026